Novel Non-Opioid Therapies in Pain Management

About Us

Committed to improving pain management for complicated, underserved conditions.

NovaPharm is a late stage drug development company focused on new treatments for Complex Regional Pain Syndrome 

NPT-001: Complex Regional Pain Syndrome


Orphan drug, breakthrough designation, phase 3 

Management Team

Michael Shine - CEO

Mike co founded NovaPharm in 2011 after 25+ years in the pharmaceutical, biotech and consumer products industries. The company is in phase 3 with its primary asset.

Paul Silver PhD - Head R&D

Paul co founded NovaPharm and with over 30 years of experience in preclinical and clinical drug development, Paul has been instrumental in leading the successful development of the company's lead compounds.

Greg Hockel - Head of Regulatory

Greg joined NovaPharm in 2016 bringing a wealth of regulatory experience across multiple therapeutic areas. 

Marco Pappagallo MD - Medical Affairs and Scientific Advisory

Marco was an original founding member of NovaPharm in 2011. He remains an active member of the Board and provides scientific and medical oversight to the company.

Contact Us

For Inquiries please complete the form below

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for your interest in NovaPharm Therapeutics